Company registration number 07238700 (England and Wales)
BERKSHIRE HEALTH LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
BERKSHIRE HEALTH LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 12
BERKSHIRE HEALTH LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
1,126,093
1,171,525
Current assets
Debtors
5
1,185,850
757,912
Cash at bank and in hand
241,784
163,212
1,427,634
921,124
Creditors: amounts falling due within one year
7
(501,139)
(432,506)
Net current assets
926,495
488,618
Total assets less current liabilities
2,052,588
1,660,143
Creditors: amounts falling due after more than one year
8
(2,037,097)
(2,137,686)
Net assets/(liabilities)
15,491
(477,543)
Capital and reserves
Called up share capital
11
100
100
Profit and loss reserves
15,391
(477,643)
Total equity
15,491
(477,543)
BERKSHIRE HEALTH LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2025
31 December 2025
- 2 -

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 17 September 2026 and are signed on its behalf by:
The financial statements were approved and signed by the director and authorised for issue on 17 September 2026
Mr J Alberto
Director
Company registration number 07238700 (England and Wales)
BERKSHIRE HEALTH LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 July 2023
100
(241,000)
(240,900)
Year ended 31 December 2024:
Loss for the period
-
(236,643)
(236,643)
Balance at 31 December 2024
100
(477,643)
(477,543)
Year ended 31 December 2025:
Profit for the year
-
493,034
493,034
Balance at 31 December 2025
100
15,391
15,491
BERKSHIRE HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
1
Accounting policies
Company information

Berkshire Health Limited is a private company limited by shares incorporated in England and Wales. The registered office is Lillibrooke Manor, Ockwells Road, Maidenhead, Berkshire, SL6 3LP.

1.1
Reporting period

The financial statements for the previous accounting period were prepared for the period from 1 July 2023 to 31 December 2024 and therefore the comparative amounts presented in the financial statements (including the related notes) are not entirely comparable.

 

1.2
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

 

During the year, the company transitioned from International Financial Reporting Standards (IFRS) to FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland. The company has elected to early adopt the amendments to FRS 102 relating to lease accounting, which are effective for accounting periods beginning on or after 1 January 2026. As a result, the accounting treatment of leases is consistent with that applied in the prior year under IFRS, and no material adjustments were required on transition in respect of lease accounting.

1.3
Going concern

The director has at the time of approving the financial statements, a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.true

1.4
Revenue

Revenue is measured at the fair value of the consideration received or receivable and is generated from the provision of specialist medical care to privately insured, NHS and self-funded patients, stated net of discounts, returns and value added taxes.

 

The Company recognises revenue when performance obligations have been satisfied day by day as treatment is provided to patients. Patient charges are captured on a daily basis as a record of the services provided and represent an appropriate measure to determine the satisfaction of performance obligations at a point in time under IFRS 15.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

BERKSHIRE HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
Over the remaining length of the lease term
Clinical equipment
Straight-line over 4-10 years
Fixtures and fittings
Straight-line over 3-4 years

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

BERKSHIRE HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 6 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, borrowings and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of inventories or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

BERKSHIRE HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 7 -
1.13
Leases
As lessee

Contracts may contain both lease and non-lease components. The Company allocates the consideration in the contract to the lease and non-lease components based on their relative stand-alone prices. Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions. The lease agreements do not impose any covenants other than the security interests in the leased assets that are held by the lessor. Leased assets may not be used as security for borrowing purposes.

 

Initial recognition and measurement

 

Leases are recognised as a right-of-use asset and a corresponding liability at the date at which the leased asset is available for use by the Company. Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the following lease payments:

 

Fixed payments (including in-substance fixed payments), less any lease incentives receivable;

Variable lease payments that are based on an index or a rate, initially measured using the index or

rate as at the commencement date;

Amounts expected to be payable by the Company under residual value guarantees;

The exercise price of a purchase option if the Company is reasonably certain to exercise that option;

and Payments of penalties for terminating the lease, if the lease term reflects the Company

exercising that option.

 

Lease payments to be made under reasonably certain extension options are also included in the measurement of the liability.

 

The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for leases in the Company, the lessee's incremental borrowing rate is used, being the rate that the individual lessee would have to pay to borrow the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment

with similar terms, security and conditions.

 

Subsequent measurement

 

After the commencement date, the Company measures the lease liability by:

a. Increasing the carrying amount to reflect interest on the lease liability;

a. Reducing the carrying amount to reflect the lease payments made; and

b. Re-measuring the carrying amount to reflect any reassessment or lease modifications or to

reflect revised in substance fixed lease payments or on the occurrence of other specific

 

Interest on the lease liability in each period during the lease term is the amount that produces a constant periodic rate of interest on the remaining balance of the lease liability. Interest charges are presented separately as non-operating costs in the income statement, unless the costs are included in the carrying amount of another asset applying other applicable standards. Variable lease payments not included in the measurement of the lease liability, are included in operating expenses in the period in which the event or condition that triggers them arises.

 

Right-of-use assets are generally depreciated over the shorter of the asset's useful life and the lease term on a straight-line basis. If the Company is reasonably certain to exercise a purchase option, the right-of use asset is depreciated over the underlying asset's useful life.

 

 

 

 

 

BERKSHIRE HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 8 -
As lessor

Lease modifications

 

The Company is exposed to potential future increases in variable lease payments based on an index or rate, which are not included in the lease liability until they take effect. When adjustments to lease payments based on an index or rate take effect, the lease liability is reassessed and adjusted against the right-of-use asset.

 

If a lease is modified, the modified contract is evaluated to determine whether it is or contains a lease. If a lease continues to exist, the lease modification will result in either a separate lease or a change in the accounting for the existing lease.

 

The modification is accounted for as a separate lease if both:

a. The modification increases the scope of the lease by adding the right to use one or more underlying assets; and

b. The consideration for the lease increases by an amount commensurate with the stand-alone price for the increase in scope and any appropriate adjustments to that stand-alone price to reflect the circumstances of the particular contract.

 

If both conditions are met, the lease modification results in two separate leases, the unmodified original lease and a separate lease. The Company then accounts for these in line with the accounting policy for new leases.

 

Short-term and low-value leases

 

The Company has made an accounting policy election, by class of underlying asset, not to recognise lease assets and lease liabilities for leases with a lease term of 12 months or less (i.e., short-term leases). The Company has made an accounting policy election on a lease-by-lease basis, not to recognise lease assets on leases for which the underlying asset is of low value. Lease payments on short-term and lowvalue leases are accounted for on a straight-line bases over the term of the lease or other systematic basis if considered more appropriate. Short-term and low-value lease payments are included in operating expenses in the income statements.

 

Subleases

 

If an underlying asset is re-leased by the Company to a third party and the Company retains the primary obligation under the original lease, the transaction is deemed to be a sublease. The Company continues to account for the original lease (the head lease) as a lessee and accounts for the sublease as a lessor (intermediate lessor). When the head lease is a short-term lease, the sublease is classified as an operating lease. Otherwise, the sublease is classified using the classification criteria applicable to Lessor Accounting in IFRS 16 by reference to the right-of-use asset in the head lease (and not the underlying asset of the head lease). After classification lessor accounting is applied to the sublease.

BERKSHIRE HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 9 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

 

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are outlined below.

 

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
26
21
4
Tangible fixed assets
Leasehold land and buildings
Clinical equipment
Fixtures and fittings
Total
£
£
£
£
Cost
At 1 January 2025
1,020,000
322,695
107,171
1,449,866
Additions
-
0
73,374
19,282
92,656
At 31 December 2025
1,020,000
396,069
126,453
1,542,522
Depreciation and impairment
At 1 January 2025
134,354
89,951
54,036
278,341
Depreciation charged in the year
36,180
72,482
29,426
138,088
At 31 December 2025
170,534
162,433
83,462
416,429
Carrying amount
At 31 December 2025
849,466
233,636
42,991
1,126,093
At 31 December 2024
885,646
232,744
53,135
1,171,525
BERKSHIRE HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 10 -
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
249,602
216,560
Amounts owed by group undertakings
572,598
-
0
Finance leases receivable
197,829
197,829
Other debtors
10,095
-
0
Prepayments and accrued income
39,641
29,610
1,069,765
443,999
2025
2024
Amounts falling due after more than one year:
£
£
Finance leases receivable
116,085
313,913
116,085
313,913
Total debtors
1,185,850
757,912

Amounts due from fellow group undertakings are interest free, unsecured and repayable on demand.

6
Finance lease receivables
2025
2024
Future amounts receivable under finance leases:
£
£
Within one year
216,000
216,000
Year 2
108,000
216,000
Year 3
-
0
108,000
Total undiscounted lease payments receivable
324,000
540,000
Unearned finance income
(10,086)
(28,258)
Present value of lease payments receivable
313,914
511,742
Finance lease receivables are classified based on the amounts that are expected to be settled within the next 12 months and after more than 12 months from the reporting date, as follows:
2025
2024
£
£
Current assets
197,829
197,829
Non-current assets
116,085
313,913
313,914
511,742
BERKSHIRE HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 11 -
7
Creditors: amounts falling due within one year
2025
2024
£
£
Lease liabilities
9
100,588
96,172
Trade creditors
110,953
117,349
Amounts owed to group undertakings
-
0
93,379
Corporation tax
113,338
-
0
Other taxation and social security
35,088
25,498
Other creditors
46,713
36,624
Accruals and deferred income
94,459
63,484
501,139
432,506

Amounts owed to group undertakings are unsecured, interest free and repayable on demand.

8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
2,037,097
2,137,686
9
Lease liabilities
2025
2024
Amounts due:
£
£
Within one year
100,588
96,172
After more than one year
2,037,097
2,137,686
2,137,685
2,233,858
2025
2024
Maturity analysis of future lease payments
£
£
Within one year
194,000
194,000
In two to five years
827,000
827,000
In over five years
2,620,000
2,814,000
Total undiscounted liabilities
3,641,000
3,835,000
Future finance charges and other adjustments
(1,503,315)
(1,601,142)
Lease liabilities in the financial statements
2,137,685
2,233,858
Other leasing information is included in note.
BERKSHIRE HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 12 -
10
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
38,201
42,136

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

11
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 1p each
10,000
10,000
100
100
12
Parent undertaking and ultimate controlling party

The immediate parent and ultimate controlling party of the Company is Berkshire Health Group Limited, a company incorporated in England, United Kingdom. Copies of the financial statements can be obtained from the Company Secretary at Lillibrooke Manor, Ockwells Road, Maidenhead, Berkshire, SL6 3LP.

2025-12-312025-01-01falsefalsefalse18 September 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr J Alberto072387002025-01-012025-12-31072387002025-12-31072387002024-12-3107238700core:PlantMachinery2025-12-3107238700core:FurnitureFittings2025-12-3107238700core:LandBuildings2024-12-3107238700core:PlantMachinery2024-12-3107238700core:FurnitureFittings2024-12-3107238700core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3107238700core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3107238700core:Non-currentFinancialInstrumentscore:AfterOneYear2025-12-3107238700core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3107238700core:ShareCapital2025-12-3107238700core:ShareCapital2024-12-3107238700core:RetainedEarningsAccumulatedLosses2025-12-3107238700core:RetainedEarningsAccumulatedLosses2024-12-3107238700core:ShareCapital2023-06-3007238700core:RetainedEarningsAccumulatedLosses2023-06-3007238700core:ShareCapitalOrdinaryShareClass12025-12-3107238700core:ShareCapitalOrdinaryShareClass12024-12-3107238700bus:Director12025-01-012025-12-3107238700core:RetainedEarningsAccumulatedLosses2023-07-012024-12-31072387002023-07-012024-12-3107238700core:RetainedEarningsAccumulatedLosses2025-01-012025-12-3107238700core:LandBuildingscore:LongLeaseholdAssets2025-01-012025-12-3107238700core:PlantMachinery2025-01-012025-12-3107238700core:FurnitureFittings2025-01-012025-12-3107238700core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-12-3107238700core:PlantMachinery2024-12-3107238700core:FurnitureFittings2024-12-31072387002024-12-3107238700core:LandBuildingscore:LeasedAssetsHeldAsLessee2025-12-3107238700core:LandBuildingscore:LeasedAssetsHeldAsLessee2025-01-012025-12-3107238700core:CurrentFinancialInstruments2025-12-3107238700core:CurrentFinancialInstruments2024-12-3107238700core:Non-currentFinancialInstruments2024-12-3107238700core:BetweenTwoThreeYears2025-12-3107238700core:Non-currentFinancialInstruments2025-12-3107238700bus:OrdinaryShareClass12025-01-012025-12-3107238700bus:OrdinaryShareClass12025-12-3107238700bus:OrdinaryShareClass12024-12-3107238700bus:PrivateLimitedCompanyLtd2025-01-012025-12-3107238700bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3107238700bus:FRS1022025-01-012025-12-3107238700bus:AuditExemptWithAccountantsReport2025-01-012025-12-3107238700bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP